Preferred
(EDT)

[Joint Session] Disease Mechanisms and Therapeutic Targets

10:10 AM - 1:00 PM EDT
Monday, June 7, 2021
Other
[Joint Session] Disease Mechanisms and Therapeutic Targets
Antisense Oligonucleotides for the Treatment of Neurological Diseases
10:10 AM - 10:35 AM EDT
Monday, June 7, 2021Room: V300 - Ian
Speaker
Speaker Image
Holly Kordasiewicz, PhD
Ionis Pharmaceuticals
[Joint Session] Disease Mechanisms and Therapeutic Targets
Speaker
Speaker Image
Joseph Lewcock, PhD
Denali Therapeutics
[Joint Session] Disease Mechanisms and Therapeutic Targets
Enhancing Microglia Function with ATV:TREM2
11:00 AM - 11:25 AM EDT
Monday, June 7, 2021Room: V300 - Ian
Speaker
Speaker Image
Kate Monroe, PhD
Denali Therapeutics
[Joint Session] Disease Mechanisms and Therapeutic Targets
Coffee Break
11:25 AM - 11:50 AM EDT
Monday, June 7, 2021
[Joint Session] Disease Mechanisms and Therapeutic Targets
Speaker
Speaker Image
Johan Luthman, PhD
Lundbeck
[Joint Session] Disease Mechanisms and Therapeutic Targets
Speaker
Speaker Image
Raz Dvir Szternfeld, MS
Weizmann Institute of Science
[Joint Session] Disease Mechanisms and Therapeutic Targets
Speaker
Speaker Image
Christiane Wrann, PhD
Massachusetts General Hospital
[Joint Session] Disease Mechanisms and Therapeutic Targets
Speaker
Speaker Image
Elise Marsan, PhD
University of California, San Francisco
[Joint Session] Disease Mechanisms and Therapeutic Targets


Copyright © 2025 Keystone Symposia
Powered by Conexiant DXP
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.